Page last updated: 2024-09-03

mk 287 and bepafant

mk 287 has been researched along with bepafant in 1 studies

Compound Research Comparison

Studies
(mk 287)
Trials
(mk 287)
Recent Studies (post-2010)
(mk 287)
Studies
(bepafant)
Trials
(bepafant)
Recent Studies (post-2010) (bepafant)
60017405

Protein Interaction Comparison

ProteinTaxonomymk 287 (IC50)bepafant (IC50)
Platelet-activating factor receptorCavia porcellus (domestic guinea pig)0.073

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bures, MG; Carrera, GM; Davidsen, SK; Guinn, DE; Heyman, HR; May, PD; Phillips, JG; Pireh, D; Sheppard, GS; Steinman, DH1

Other Studies

1 other study(ies) available for mk 287 and bepafant

ArticleYear
3-(2-(3-Pyridinyl)thiazolidin-4-oyl)indoles, a novel series of platelet activating factor antagonists.
    Journal of medicinal chemistry, 1994, Jun-24, Volume: 37, Issue:13

    Topics: Administration, Oral; Animals; Capillary Permeability; Edema; In Vitro Techniques; Indoles; Magnetic Resonance Spectroscopy; Male; Mice; Platelet Activating Factor; Rabbits; Rats; Rats, Sprague-Dawley; Serotonin; Skin; Stereoisomerism; Structure-Activity Relationship; Thiazoles

1994